1414968-25-4 Usage
Uses
Used in Pharmaceutical Research:
[1-(4-aminomethyl-benzenesulfonyl)-piperidin-4-yl]-carbamic acid tert-butyl ester is used as a research compound for its potential biological activity and structural importance in the development of new pharmaceuticals. Its unique molecular structure may contribute to the discovery of novel therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, [1-(4-aminomethyl-benzenesulfonyl)-piperidin-4-yl]-carbamic acid tert-butyl ester is used as a protective group for carbamic acid. This application allows chemists to control the reactivity of the molecule during specific reaction conditions, facilitating the synthesis of more complex organic compounds.
Used in Drug Manufacturing:
[1-(4-aminomethyl-benzenesulfonyl)-piperidin-4-yl]-carbamic acid tert-butyl ester is employed as an intermediate in the manufacturing of pharmaceuticals. Its structural features and potential biological activity make it a valuable component in the production of various drugs.
Used in Chemical Safety and Handling:
[1-(4-aminomethyl-benzenesulfonyl)-piperidin-4-yl]-carbamic acid tert-butyl ester is also used as a case study in the development of safety protocols and best practices for handling potentially hazardous chemicals in the pharmaceutical industry. Understanding the properties and reactivity of [1-(4-aminomethyl-benzenesulfonyl)-piperidin-4-yl]-carbamic acid tert-butyl ester helps in designing appropriate safety measures and guidelines for its use in research and manufacturing settings.
Check Digit Verification of cas no
The CAS Registry Mumber 1414968-25-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,4,9,6 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1414968-25:
(9*1)+(8*4)+(7*1)+(6*4)+(5*9)+(4*6)+(3*8)+(2*2)+(1*5)=174
174 % 10 = 4
So 1414968-25-4 is a valid CAS Registry Number.
1414968-25-4Relevant academic research and scientific papers
TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
-
, (2012/12/13)
Certain compounds and pharmaceutically acceptable salts are provided herein. Also provided are pharmaceutical compositions comprising at least one compound or pharmaceutically acceptable salt therein and one or more pharmaceutically acceptable vehicle. Methods of treating patients suffering from certain disease states responsive to the inhibition of transglutaminase TG2 activity are described. These disease states include neurodegenerative disorders such as Huntington's disease. Also described are methods of treatment include administering at least one compound or pharmaceutically acceptable salt thereof as a single active agent or administering at least one compound or pharmaceutically acceptable salt thereof in combination with one or more other therapeutic agents.
